Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹3.0 LQualified Make: Unbranded--DAFFODILLS PHARMACEUTICAL LIMITED
Model: Tablet 7 DAFFODILLS PHARMACEUTICALS LTD ROHTA ROAD JAWAHAR NAGAR MEERUT UTTAR PRADESH 250001 | MEERUT | UTTAR PRADESH | 250001 | Make: Unbranded--DAFFODILLS PHARMACEUTICAL LIMITED
Model: Tablet | L1 | Qualified MSE, Category: General |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
9 Aug 2024, 3:00 pmClosed
Anti TB Drugs - Isoniazid 300 mg Tablet (Q1)
6707726
GEM/2024/B/5221514
Two Packet Bid
Anti TB Drugs - Isoniazid 300 mg Tablet
GeM Contract
45 days
Uttar Pradesh; Moradabad
Total value wise evaluation
PRODUCT
Awarded to DAFFODILLS PHARMACEUTICAL LIMITED
₹3.0 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Unbranded--DAFFODILLS PHARMACEUTICAL LIMITED Isoniazid 300 mg Tablet | Unbranded--DAFFODILLS PHARMACEUTICAL LIMITED / Tablet | HSN not specified by seller | 27,000 strip | 11 | 297,000 |
6 documents required · 6 mandatory
3 yrs
₹3
20%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Anti TB Drugs - Isoniazid 300 mg Tablet (Q1) | Sandeep Badola 244001,CMO Office, Civil Lines | 27,000 | 45 days |
Exempted
28 Sept 2024
30 Jul 2024
9 Aug 2024
contract_GEMC-511687748146501.pdf
GEM_CONTRACT • 0.09 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6707726.pdf
GEM_BID
isoniazid-300mg-pc-11-updated-feb-2021_2022-04-13-12-48-05_eeb1caa0dee44e836051b46bc7819ed1.pdf
OTHER
ACC_a0804e9a-826f-4241-b06d1722254079831_cmsdmbd1.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .